Event Content

In today’s rapidly evolving global landscape, the (bio-)pharmaceutical industry faces increasing complexity, from shifting market dynamics to rising sustainability expectations. The keynote explores how long-term, trust-based relationships between Contract Development and Manufacturing Organizations (CDMOs...

This session will address the critical challenges facing today's high-pressure pharmaceutical development landscape, where every decision carries significant weight for companies ranging from emerging biotechs navigating investment challenges on their path to IND, to established biopharma organizations sca...

In this session, Aaron Dely, Vice President of R&D at PLD Pharma Services, explores the opportunities and challenges of developing over-the-counter (OTC) and Rx gummies. Dely explains why consumer demand for gummies—driven by improved compliance—is fueling rapid growth and premium pricing in this dosage fo...

The BioSecure Act, and the actions that Chinese companies have taken as a result, is much more than what meets the eye. It is reflective of the successes and failures of the Chinese biotech industry over the past decade, and provides lessons for the entire industry.

The field of advanced therapies, including cell and gene therapies, hold the promise for groundbreaking new ways to treat patients but, how do we fulfill the promise that they hold? How will we accelerate their path to patients who are waiting? - As the field of advanced therapies continues to grow, so d...

Remote monitoring is transforming the landscape of clinical trials by making participation more accessible to patients, regardless of location. Home-based trials, supported by advanced remote monitoring technology, eliminate the need for frequent site visits, enabling patients to engage in trials from the ...

Explore how stronger supplier partnerships can help the pharmaceutical industry build resilient, sustainable supply chains. Learn strategies for reducing environmental impact, enhancing risk management, and aligning with global sustainability goals to ensure a robust, future-ready supply network.
•...

With growing pressure to reduce emissions, a collaborative approach is essential. This workshop will explore innovative strategies to transform value chains. This 75-min session will demonstrate how to build sustainable supply chains based on experience out of the Alliance to Zero’s work and via interactiv...

Device reusability has gained increasing attention in recent years, owing toits potential to reduce both the costs and environmental impact of drug delivery devices. This has made reusable autoinjectors an appealing and potentially more sustainable option, especially when considering chronic conditions whi...

Did you know that the healthcare industry contributes to approximately 5% of global GHG emissions? • To tackle this challenge, healthcare and pharmaceutical companies need to strengthen their focus on sustainability and circularity. Preparing for the Packaging and Packaging Waste Regulation (PPWR) is ...

Existing and upcoming trends for plant-based extracts represent a challenge for softgel manufacturers – as potential extreme crosslinking components. • With RXL® Ultra, GELITA re-focusses on an established, but hidden/un-noticed, solution to conquer these crosslinking challenges. As part of the RXL®-pro...

Understand the potential of the microbiome in shaping the future of therapeutics. Dive into the latest technological innovations propelling microbiome research forward, uncovering new insights and possibilities. • Discover the latest research findings with the microbiome • Exploring microbiome infl...

Join us as we explore the role sustainability professionals within organizations to shape and drive the sustainability ambition and agenda. Discover how sustainability professionals—from leaders to cross-functional teams—are shaping a culture of environmental responsibility, streamlining actions towards ne...

During pharmaceutical product development, Boehringer Ingelheim generates hundreds of thousands of documents, each containing valuable knowledge and problem-solving strategies. • The challenge is to make this knowledge accessible within the company to avoid redundant efforts. To address this, Boehrin...

Ingenza is changing the game in drug substance production by embracing the concept of employing the best of what both chemistry and biology have to offer. We integrate fermentative, biocatalytic and chemical synthetic transformations at any stage in the manufacturing process. We are versatile and adaptable...

The following session has been SOLD OUT. For any inquiries, please contact a member of staff on the day Take a break from the show floor and join us for a bite, network with colleagues, and stay informed with the latest updates and insights on US Pharma regulations. Join attorneys from Womble Bond Dickin...

Discover the compelling link between employee wellness, engagement, and company success. Learn practical strategies to enhance employee well-being, boost recruitment efforts, and cultivate a positive corporate culture. Explore how wellness initiatives drive sales performance and leadership effectiveness. G...

Major players in the pharmaceutical supply chain are increasingly looking towards CPOs to outsource an essential step of drug production and distribution, but what are the opportunities and challenges to consider before moving forward?

Join us as we dive into the key considerations of choosing a CDMO as a biotech, and how to select the perfect partner: • Establishing a pre-partner checklist of what you need (regulation, manufacturing technology, and logistics) to avoid unnecessary costly measures • Why understanding your molecul...

A global leader with over 40 years of biologics manufacturing experience. Decades of partnerships with highly regarded pharmaceutical and biotechnology companies around the world, paired with scalable cGMP-compliant facilities and industry-leading technology, mean we have the knowledge and tools to provide...

This session offers guidance on innovative patient-centric approaches to packaging design.
• Outlining the importance of primary packaging and the need for patient involvement • How involving patients in early development can help improve compliance and product durability from the design process...

Highly Potent APIs are a rapidly growing segment of the global pharmaceutical industry, and they are acquiring a significant relevance into the development space. The importance to understand the challenges around development of High Potency Oral solids formulations, are the key to ensure a right scale-up ...

With US Pharma pledging to become net-zero by 2050, you must have the right processes. Join our focused panel where our experts will discuss the best ways to implement ESG in your organization: • Defining ESG in Pharma to understand what makes it different from other industries • Establishing what i...

AI an ever growing in pharma and is playing a prominent role in drug development. Listen to the latest developments in AI and what you need to know to utilize its potential in drug development. Join our focused session to get key takeaways from our expert: • Understanding what AI can bring to your orga...

Join our focused session, where our market expert will provide an insightful analysis of the supply chain set-up from the pandemic to now. Understand the industry learnings from Covid and what has evolved within the supply chain industry: • Reviewing current developments in pharmaceutical supply chain ...

Where QBD was the orchestral sheet music that determined how drug product development has been harmonized over the last 15 or so years, contemporary patient-centric risk-based approaches to drug development are the pop evolution. The music is still beautiful when produced well - but the focus is no longer...

Human Factors Engineering (HFE) process participates in the product development for a safe and effective use by the end-user population. HFE data are under agencies' scrutiny as part of the design control of a drug - device combination product. Timely planning can be challenging during combination product ...

The presentation will focus on pressing over the pain points of Pharma Manufacturing, where we present the ECOSYSTEM of Körber Pharma as a great solution. I plan to address the burning questions - What is an Ecosystem and why is it so important in Pharma Manufacturing? The specific details on exploring ...

As the number of patients managing chronic diseases continues to increase, self-injection solutions play an important role in enabling the shift towards home care. Identification of potential use errors is a critical task during device development to support patient acceptance and usability. The design of ...

Implementing sustainability in pharmaceutical packaging needs a two-way methodology: on the one hand, a scientific, data-driven approach to support today’s industrial solutions; on the other hand, a ground-breaking , never-stopping innovation research to anticipate future evolutions. With this Learning...

The pipeline for advanced genetic therapies has grown exponentially since 2014, and now totals over 3,500 different developmental candidates. This session provides a comprehensive global snapshot of this R&D landscape, spanning gene, cell, and RNA-based drug modalities. This includes analysis of drug pipel...

mRNA has been called the software of life. It can help treat everything from cancer to cardiovascular diseases and can be used on high-scale as well as for niche indications. Covid-19 has put mRNA technology in the spotlights. The technology is therefore appealing to investors. However, how are these medic...

Rapid climate change has direct impacts on human health. These arise from multiple causes, including severe weather, changing ecology of disease vectors, increased allergens, and geopolitical conflict over scarce resources.
Healthcare itself contributes to climate change because of its sizeable carb...

The next generation enteric capsule enables pharmaceutical companies to develop a targeted delivery solution while simplifying their manufacturing processes.

The solution offers: • An acid-protective dosage form with enteric drug release through a patient centric delivery solution; • A sim...

In this webinar, originally broadcast as a part of Pharmapack Europe, Eve-Marie Vaccaro, Global Sales & Operation Planner, and Edgar Bauer, Global Key Account Manager Bausch+Ströbel from BD Medical - Pharmaceutical Systems discuss how VHP sterilization is a viable alternative for ensuring improved patient ...

In this webinar, originally broadcast as a part of Pharmapack Europe 2022, speakers from STERIS will be describing the methodology for transferring the sterilization process of medical or pharma products from one radiation technology to another (e.g. gamma to X-ray).

In this webinar, originally broadcast as part of the Pharmapack Europe show, Katsuyuki Takeuchi, Associate Product Manager, Terumo Europe NV will discuss how the world, and in particular the world of Plastics needs to change its Consumption, Production and Value Creation practices. Global Challenges such a...

In this webinar, originally broadcast as part of the Pharmapack Europe show, speaker Aurelio Areas, Engagement Manager, IQVIA will give us a look at the global outlook of the pharma industry as it emerges from the pandemic with a focus on drug delivery trends. This session analyses current dynamics in drug...

Focus on Medicines for All's work in process improvements for COVID therapeutics, including work done thus far on remdesivir and molnupiravir. The session will also describe how Medicines for All shares its results with the global market and how this has led to uptake of its processes on critical COVID dru...

As the healthcare landscape continues to change, the results can deeply impact the economics of a practice. This session will discuss medical vs pharmacy benefit trends, PBMs, national and government payer changes, and how to stay five steps ahead for community based physicians and infusion centers. This s...

In this webinar is originally broadcast as part of CPHI North America, with speakers Robert Bloder, Chief Business Officer, Ascendia Pharma, Chris Senanayake, CEO & CSO, TCG GreenChem, Inc. and John Pennett, Partner-in-Charge of the National Technology and Life Sciences Group, EisnerAmper. The thread line:...

Q&A featuring Raman Sehgal, host of Molecule to Market and Stephanie Watson, Global Strategy and Commercial Planning Lead at Pfizer CentreOne Diving into the biggest challenges the supply chain are currently facing, as well as potential solutions Dissect successful responses and shed light on the future tr...